The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

Pacchiarotti, Isabella; Bond, David; Baldessarini, Ross; Nolen, Willem; Grunze, Heinz; Licht, Rasmus; Post, Robert; Berk, Michael; Goodwin, Guy; Sachs, Gary; Tondo, Leonardo; Findling, Robert; Youngstrom, Eric; Tohen, Mauricio; Undurraga, Juan; Gonzalez-Pinto, Ana; Goldberg, Joseph; Yildiz, AYŞEGÜL; Altshuler, Lori; Calabrese, Joseph; Mitchell, Philip; Thase, Michael; Koukopoulos, Athanasios; Colom, Francesc; Frye, Mark; Malhi, Gin; Fountoulakis, Konstantinos; Vazquez, Gustavo; Perlis, Roy; Ketter, Terence; Cassidy, Frederick; Akiskal, Hagop; Azorin, Jean-Michel; Valenti, Marc; Mazzei, Diego; Lafer, Beny; Kato, Tadafumi; Mazzarini, Lorenzo; Martinez-Aran, Anabel; Parker, Gordon; Souery, Daniel; Ozerdem, Aysegul; McElroy, Susan; Girardi, Paolo; Bauer, Michael; Yatham, Lakshmi; Zarate, Carlos; Nierenberg, Andrew; Birmaher, Boris; Kanba, Shigenobu; El-Mallakh, Rif; Serretti, Alessandro; Rihmer, Zoltan; Young, Allan; Kotzalidis, Georgios; MacQueen, Glenda; Bowden, Charles; Ghaemi, S.; Lopez-Jaramillo, Carlos; Rybakowski, Janusz; Ha, Kyooseob; Perugi, Giulio; Kasper, Siegfried; Amsterdam, Jay; Hirschfeld, Robert; Kapczinski, Flavio; Vieta, Eduard

doi:10.1176/appi.ajp.2013.13020185

The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders

Pacchiarotti I., Bond D. J., Baldessarini R. J., Nolen W. A., Grunze H., Licht R. W., ...Daha Fazla

AMERICAN JOURNAL OF PSYCHIATRY, cilt.170, sa.11, ss.1249-1262, 2013 (SCI-Expanded, SSCI, Scopus)

Yayın Türü: Makale / Derleme
Cilt numarası: 170 Sayı: 11
Basım Tarihi: 2013
Doi Numarası: 10.1176/appi.ajp.2013.13020185
Dergi Adı: AMERICAN JOURNAL OF PSYCHIATRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
Sayfa Sayıları: ss.1249-1262
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Objective: The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. When conclusive evidence is lacking, expert consensus can guide treatment decisions. The International Society for Bipolar Disorders (ISBD) convened a task force to seek consensus recommendations on the use of antidepressants in bipolar disorders.